TY  - JOUR
AU  - Santos-Lasaosa, S
AU  - Cuadrado, M L
AU  - Gago-Veiga, A B
AU  - Guerrero-Peral, A L
AU  - Irimia, P
AU  - Láinez, J M
AU  - Leira, R
AU  - Pascual, J
AU  - Porta-Etessam, J
AU  - Sánchez Del Río, M
AU  - Viguera Romero, J
AU  - Pozo-Rosich, P
PY  - 2017
DO  - 10.1016/j.nrl.2017.09.003
UR  - http://hdl.handle.net/10668/11842
T2  - Neurologia (Barcelona, Spain)
AB  - In the field of headaches, onabotulinumtoxinA (onabotA) is well established as a treatment for chronic migraine (CM). In recent years, it has been used increasingly to treat other primary headaches (high-frequency episodic migraine,...
LA  - en
KW  - Cefalea en racimos
KW  - Cefalea numular
KW  - Cluster headache
KW  - Hemicrania continua
KW  - Hemicránea continua
KW  - Migraine
KW  - Migraña
KW  - Neuralgia del trigémino
KW  - Nummular headache
KW  - OnabotulinumtoxinA
KW  - Trigeminal neuralgia
KW  - Botulinum Toxins, Type A
KW  - Clinical Trials as Topic
KW  - Diagnosis, Differential
KW  - Guidelines as Topic
KW  - Headache
KW  - Humans
KW  - Migraine Disorders
KW  - Trigeminal Neuralgia
TI  - Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine.
T2  - Evidencia y experiencia del uso de onabotulinumtoxinA en neuralgia del trigémino y cefaleas primarias distintas de la migraña crónica.
TY  - research article
VL  - 35
ER  -